Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4073736 | 0.88 | PTGS2 (0.38) | — | |
| SCHEMBL3853509 | 0.88 | PTGS2 (0.38) | — | |
| SCHEMBL2817918 | 0.72 | SIGMAR1 (0.43) | — | |
| SCHEMBL2817921 | 0.72 | SIGMAR1 (0.43) | — | |
| SCHEMBL10073907 | 0.59 | CTSC (0.43) | CTSCMAPT | |
| SCHEMBL1773966 | 0.54 | TTR (0.46) | — | |
| SCHEMBL31649854 | 0.53 | KDM1A (0.32) | — | |
| SCHEMBL31650647 | 0.53 | KDM1A (0.32) | — | |
| Benzyl Alcohol SCHEMBL28201559 | 0.53 | TSHR (0.58) | NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL26987794 | 0.53 | KDM1A (0.37) | NPC1POLBRAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2117309-A1 | BICYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck & Co., Inc. (US) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008085509-A1 | BICYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2008-07-17 | — | — | WO | disclosed |